INTEGRATED NON-CLINICAL AND CLINICAL RISK ASSESSMENT TO OBVIATE THE NEED FOR A DEDICATED QTC STUDY OF IXAZOMIB IN CANCER PATIENTS.

被引：0
|
作者：
Gupta, N. [1 ]
Huh, Y. [2 ]
Hutmacher, M. M. [2 ]
Ottinger, S. [1 ]
Hui, A. [1 ]
Venkatakrishnan, K. [1 ]
机构：
[1] Millennium Pharmaceut Inc, Cambridge, MA USA
[2] A2PG, Ann Arbor, MI USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PC-05
引用
收藏
页码：S6 / S6
页数：1
相关论文
共 50 条
  • [41] Observations with alpelisib in older patients (≥ 65 year of age) with breast cancer in a non-clinical trial setting
    Almodallal, Yahya
    Le-Rademacher, Jennifer G.
    Cook, Kathryn D.
    Yadav, Siddhartha
    Singh, Amrit B.
    Lee, Minji
    Lammert, Lisa M.
    Jatoi, Aminah
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 188 (01) : 15 - 20
  • [42] Observations with alpelisib in older patients (≥ 65 year of age) with breast cancer in a non-clinical trial setting
    Yahya Almodallal
    Jennifer G. Le-Rademacher
    Kathryn D. Cook
    Siddhartha Yadav
    Amrit B. Singh
    Minji Lee
    Lisa M. Lammert
    Aminah Jatoi
    Breast Cancer Research and Treatment, 2021, 188 : 15 - 20
  • [43] Non-clinical safety evaluation and risk assessment to human of aleglitazar, a dual PPAR α/γ agonist, and its major human metabolite
    Bopst, Martin
    Atzpodien, Elke-Astrid
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2017, 86 : 107 - 116
  • [44] Critical review of renal tubule karyomegaly in non-clinical safety evaluation studies and its significance for human risk assessment
    Hard, Gordon C.
    CRITICAL REVIEWS IN TOXICOLOGY, 2018, 48 (07) : 575 - 595
  • [45] Risk assessment of lymph node metastasis before surgery in endometrial cancer: Do we need a clinical trial for low-risk patients?
    Kang, Sokbom
    Todo, Yukiharu
    Watari, Hidemichi
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2014, 40 (02) : 322 - 326
  • [46] Assessment of cervical spine CT scans by emergency physicians: A comparative diagnostic accuracy study in a non-clinical setting
    van der Kolk, Brigitta Y. M.
    van den Wittenboer, Gabriella J.
    Warringa, Niek
    Nijholt, Ingrid M.
    van Hasselt, Boudewijn A. A. M.
    Buijteweg, Lonneke N.
    Schep, Niels W. L.
    Maas, Mario
    Boomsma, Martijn F.
    JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN, 2022, 3 (01)
  • [47] Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese patients.
    Akamatsu, Shusuke
    Takata, Ryo
    Takahashi, Atsushi
    Inoue, Takahiro
    Kubo, Michiaki
    Kamatani, Naoyuki
    Inazawa, Johji
    Fujioka, Tomoaki
    Habuchi, Tomonori
    Ogawa, Osamu
    Nakamura, Yusuke
    Nakagawa, Hidewaki
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] Comparison of methods for thromboembolic risk assessment with clinical perceptions and awareness in real life medical patients. COMPASS-Med study
    Gerotziafas, G. T.
    Katsamouis, A.
    Lioupis, A.
    Kiskinis, D.
    Tsolakis, J.
    Tsimogiannis, E.
    Koukos, A.
    Spyropoulos, A.
    Galea, V
    Debrix, I
    Bacouche, H.
    Elalamy, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 249 - 250
  • [49] Do Non-Clinical Factors Improve Prediction of Readmission Risk? Results From the Tele-HF Study
    Krumholz, Harlan M.
    Chaudhry, Sarwat I.
    Spertus, John A.
    Mattera, Jennifer A.
    Hodshon, Beth
    Herrin, Jeph
    JACC-HEART FAILURE, 2016, 4 (01) : 12 - 20
  • [50] Physical activity for cancer patients Clinical risk assessment for exercise clearance and prescription
    Burr, Jamie F.
    Jones, Lee
    Shephard, Roy J.
    CANADIAN FAMILY PHYSICIAN, 2012, 58 (09) : 970 - 973
12345